-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on GeneDx Holdings, Lowers Price Target to $130

Benzinga·02/24/2026 16:40:54
Listen to the news
Piper Sandler analyst David Westenberg maintains GeneDx Holdings (NASDAQ:WGS) with a Overweight and lowers the price target from $160 to $130.